Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON THE “OLD” CHROMATIN
Lezhava T, Jokhadze T, Monaselidze J, et al.
Georgian medical news;(335):79-83
[Peptidergic regulation of expression of cellular aging marker proteins in buccal epithelium.]
Ivko OM, Trofimova SV, Trofimov AV, et al.
Advances in gerontology = Uspekhi gerontologii;37(5):516-524
[Semaglutide-induced acute-on-chronic liver failure: A case report and literature review]
Fu R, Wu H, Huang H, et al.
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences;51(2):213-220
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
Lee E, Burgess K
Alternative therapies in health and medicine;31(5):20-24
Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like-Peptide-1 Use Following 10-Session Cognitive-Behavioural Therapy for Binge-Eating Disorder: A Single-Case Experimental Design
Dunford A, Yee S, Thomas JJ, et al.
European eating disorders review : the journal of the Eating Disorders Association, 2026
Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in Spain
Altés A, Moreno-Pérez Ó, Sastre-Belío M, et al.
Advances in therapy, 2026
Synergistic Intervention for Obesity: Integrating Central Appetite Regulation and Peripheral Energy Expenditure
Xie J, Yang Y, Chen W, et al.
Current obesity reports, 2026;15(1)
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
Bajaj HS, Welch M, Shah P, et al.
Lancet (London, England), 2026
Weight Loss Associated with Semaglutide Use is Linked to Improved Reproductive Measures in PMOS: a Proof-Of-Concept Analysis
Cree MG, Garcia-Reyes Y, Shapiro A, et al.
Fertility and sterility, 2026
Copper(II)-Tripeptide Complexes as Potential Skin Healing Agents: Synthesis, Characterization, and Wound Repair Ability
Aguilar L, Garcia Gabastú E, Schaffner M, et al.
ChemMedChem;21(8):e202501023
Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes
Eldesouki MH, Alkasabrah O, Kloub M, et al.
United European gastroenterology journal;14(5):e70238
Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation
Mazza AD
Integrative medicine (Encinitas, Calif.);25(2):29-37
Biomimetic Hematoma Enables Healing in Complex Periprosthetic Fracture Nonunion with Multiple Comorbidities: A Case Report
Maestas A, Glatt V, Alderete JF
JBJS case connector, 2026;16(2)
Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety
Vinciguerra F, Di Stefano C, Guccione F, et al.
Obesity surgery, 2026
Dual GIP/GLP-1 receptor agonist tirzepatide ameliorates hepatic steatosis and inflammatory responses in a MASLD mouse model associated with the CCL2/CCR2 axis
Pan Y, Song F, Liu X, et al.
BMC gastroenterology, 2026
Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
Piraccini BM, Vañó-Galván S, Blume-Peytavi U, et al.
Dermatology and therapy, 2026
Rates of, Reasons for, and Reactions to Discontinuation of GLP-1 Receptor Agonists: A Narrative Review
Heisey HD, Gregg LP, Verrico CD, et al.
Diabetes, obesity & metabolism, 2026
A subphenotype of obesity with reduced enteroendocrine GLP-1 synthesis and enhanced tirzepatide response
Ticho AL, McRae AN, Cifuentes L, et al.
Gastroenterology, 2026
Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic care
Samajdar SS, Joshi S, Saboo B, et al.
Diabetology international, 2026;17(3):59
Quality of life, morbidity, mortality, and long-term prognosis after craniopharyngioma
Müller HL
Frontiers in endocrinology, 2026;17:1768254